Diana Olusanmi is one of MaRS 21 Canadian tech entrepreneurs to watch in 2021

January 8, 2021

Diana Olusanmi moves the needle on fertility options

Despite all the developments made in reproductive science since the first “test tube” baby was born in 1978, there was still no test available to gauge the quality of a human egg. So Future Fertility, led by Diana Olusanmi, set out to change that. Her company offers AI-driven software that can calculate the health and reproductive likelihood of a human egg based on a 2D image. “There is a strong demand for greater transparency,” says Olusanmi. Since launching its first product this September, Future Fertility has heard from fertility clinics from all over the EU, Brazil, Malaysia and Japan.

What’s next: Future Fertility’s top priority for 2021 is to further refine the product and increase accuracy, which is currently 20 percent better than embryologists at predicting the likelihood of an egg becoming an embryo. The company is planning to close a Series A funding round in the first quarter of next year.

> See the article

Related posts

January 08, 2021

Women May Soon Start Using AI to Tell Good Eggs From Bad

Future Fertility, the first company to use artificial intelligence to grade the viability of women’s harvested eggs for use in [...]
December 28, 2020

If Egg Quality Matters for Egg Freezing, Why Can’t we Measure it? A Look at the Future of Freezing

“Egg quality” is touted as the single most important aspect of fertility treatments such as egg freezing as IVF. That’s [...]
April 30, 2019

Toronto-based Future Fertility wants to improve IVF with AI

Putting eggs on ice and In vitro fertilization (IVF) options are growing in popularity with millennials, but these techniques don’t [...]